HIBT Lab! Immunai: Noam Solomon

How I Built This · 22 Dec 2022 · 33m

What this episode covers

Noam Solomon, co-founder and CEO of Immunai, explains how his company is using artificial intelligence and single-cell data to create an atlas of the human immune system. Solomon describes the challenge of bridging the gap between animal models and human immune responses to improve drug development efficiency. He details how Immunai partners with pharmaceutical companies to analyze clinical trial data, helping to identify effective therapies and predict patient outcomes for diseases like cancer.

Other shows on the same ground, closest first.

  • The Next Byte Podcast · 24m

    113. The Secret Weapon In The Fight Against Rare Diseases

    Hosts Daniel and Forbode discuss a Stanford Human Centered Artificial Intelligence Group study that uses an AI model called PopDX to detect rare diseases in the UK Biobank despite incomplete patient data. The hosts explain how the algorithm infers missing diagnosis codes with high precision, improving characterization of unseen diseases by 218% and rare diseases by 151% compared to existing algorithms. They also highlight the researchers' acknowledgment of demographic biases in the training data and the potential for this technology to accelerate medical research and treatment for rare conditions.

  • The Next Byte Podcast · 31m

    63. Immune System Inspired AI & Electric Skin

    Hosts Daniel and Forbode discuss two recent engineering breakthroughs inspired by biology. First, they cover research from the University of Michigan on 'RAILS' (Robust Adversarial Immune-inspired Learning System), which uses B-cell immune system logic to make AI image classifiers robust against adversarial attacks. Second, they analyze electronic skin developed by Pohang University of Science and Technology (POSTECH) and UNIST, which mimics human nerve pathways to achieve low-latency tactile sensing for robotics and prosthetics.

  • IoT For All Podcast · 23m

    Generative AI and Emotional Intelligence | millionways' Martin Cordsmeier & Max Weidemann | Internet of Things Podcast

    Martin Cordsmeier and Max Weidemann, co-founders of millionways, discuss their New York-based AI company's focus on 'scientific AI' versus generative AI. They explain how their technology analyzes text to create personality profiles and psychological backgrounds, aiming to provide explainable, bias-aware insights for mental health and HR applications. The founders argue that AI should act as a scientific tool to help people understand themselves rather than replacing human judgment, highlighting specific use cases like university matchmaking and veteran mental health support.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by How I Built This. The episode itself belongs to its publisher.